Navigation Links
Inadequate epilepsy treatment

The diagnosis and treatment of epilepsy is often handled in a casual “insouciant” manner, with up to 20 per cent of UK epilepsy patients not receiving appropriate drugs, researchers say. Around 30,000 people are diagnosed with epilepsy each year, and of these, about one-third can be expected to continue on long-term medication. But researchers from the Institute of Neurology at University College London have found that some epilepsy treatment regimes are outmoded, inappropriate or given too late to be of maximum benefit to patients. //

The team monitored the treatment patterns of 564 epilepsy patients for up to 14 years after diagnosis. Their work forms part of the United Kingdom General Practice Study of Epilepsy – a long-term population-based study of the condition.

The researchers found that less than half of epilepsy patients with partial seizures and less than a third with generalised seizures were treated with recommended treatments. Only 11 per cent of patients received the latest medication and 7 per cent had been kept on the same drug despite failing to achieve remission after two years.

UK doctors are reluctant to prescribe drugs to patients who have had one seizure, the researchers say. About 15 per cent of the patients monitored received drugs after their first epileptic seizure, although high rates of recurring seizures meant that more than 75 per cent of the group received treatment at some point.

'"/>




Page: 1

Related medicine news :

1. Inadequate Drug Treatment For Youth
2. Inadequate proof to justify routine prostate screen
3. Sterilization Of Dental Instruments Is Inadequate, Says Study
4. Inadequate labeling in sandwiches sold at UK supermarkets
5. Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims
6. Training in Australias Medical Schools Inadequate
7. Inadequate Mental Health Fundings, Experts Warn
8. AMA Warns Of Inadequately Trained Doctors Due To Lack of Resources
9. Treatment For ADHD In Kids Inadequate
10. Healthcare Inadequate at Yarl’s Wood Immigration Cente
11. Inadequate Communication Reduces Benefits of Mammogram Screening for Black Women
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a point to lead ... reduce waste, and support renewable energy. They believe this is a crucial part of ... solutions for health issues, and maintain that destroying the environment in the pursuit of ...
(Date:4/24/2017)... ... ... , a national non-profit organization focusing on the prevention and early detection of breast and ... to announce Katie Thiede as their new Chief Executive Officer. In January, founder Lindsay Avner ... Board and launched a national search to find a visionary new leader to grow Bright ...
(Date:4/24/2017)... ... April 24, 2017 , ... The John P. McGovern Museum of Health and ... to track their cognitive health, and share results with their physicians. Members and guests ... the museum's website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... within the telehealth industry, announces the company’s VideoMedicine mobile platform has launched Quick ... Available 24 hours a day, Quick Care provides patients with the option to ...
(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health Management announced today ... people with addiction who are served by MAP’s patient engagement ecosystem. Lief Therapeutics ... monitors heart and breath rates to identify anxiety levels and can provide biofeedback ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: